Andover to acquire SRS Medical
This article was originally published in Clinica
Andover Medical has signed a letter of intent to acquire fellow Massachusetts firm SRS Medical, of Billerica. SRS Medical, which makes noninvasive devices for incontinence, will be the North Andover acquisition-focused firm's first purchase in the incontinence and women's health markets. It says it intends to establish a nationwide network of subsidiaries to offer "the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.